Author Question: Which one of the following communication approaches would be appropriate during the growth and ... (Read 46 times)

Sufayan.ah

  • Hero Member
  • *****
  • Posts: 512
Which one of the following communication approaches would be appropriate during the growth and maturity stages of the product life cycle?
 A) informational
  B) informational and persuasive
  C) persuasive
  D) persuasive and reminder
  E) reminder

Question 2

May firms, like the Altria Group, focus on diversification in their marketing strategies because they possess:
 A) many internal strengths and many external opportunities.
  B) many internal weaknesses and many external opportunities.
  C) many internal strengths and few external opportunities.
  D) many internal strengths and many external threats.
  E) many internal weaknesses and many external threats.



DHRUVSHAH

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

B

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

The liver is the only organ that has the ability to regenerate itself after certain types of damage. As much as 25% of the liver can be removed, and it will still regenerate back to its original shape and size. However, the liver cannot regenerate after severe damage caused by alcohol.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library